RTL Genomics specializes in next-generation sequencing (NGS) solutions, leveraging advanced technologies such as the Illumina MiSeq and NovaSeq 6000 platforms. These cutting-edge systems enable the company to provide a wide range of sequencing services, including targeted gene and shotgun sequencing applications. RTL Genomics is recognized for its exceptional turnaround times, typically delivering results within 3.5 weeks from sample receipt to NGS results. The company prides itself on offering highly accurate and reliable analysis, supported by extensive bioinformatics and biostatistics expertise, which is crucial for clients aiming to publish their findings.

Founded in 2004, RTL Genomics has a rich history of innovation in molecular diagnostics, initially focusing on infectious disease care through techniques like qPCR and DNA sequencing. As a pioneer in 16S amplicon sequencing, the company has significantly contributed to the fields of metagenomics and microbial ecology. With a commitment to customized solutions and unparalleled customer service, RTL Genomics has established itself as a leader in the industry, processing over 184,000 samples and serving a diverse clientele that includes universities, governmental bodies, and Fortune 500 companies. The acquisition by MicroGen Diagnostics in 2020 has further enhanced its technical capabilities, positioning RTL Genomics at the forefront of scientific discovery.

United States

RTLGenomics is a full service sequencing company offering sequencing approaches including barcoding, metagenomicsand transcriptomics. A sister lab, MicroGen, is a CAP accredited clinical diagnostic laboratory.

RTLGenomics

Company Details